| Accession Number | 0001140361-26-036390 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 11, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Sep 11, 2026 | Sale to Issuer | 8,437 | โ | โ | 0 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Sep 11, 2026 | Sale to Issuer | 10,000 | โ | โ | 0 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Sep 11, 2026 | Sale to Issuer | 50,400 | โ | โ | 0 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Sep 11, 2026 | Sale to Issuer | 28,608 | โ | โ | 0 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Sep 11, 2026 | Sale to Issuer | 372,701 | โ | โ | 0 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Sep 11, 2026 | Sale to Issuer | 673,808 | โ | โ | 0 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Sep 11, 2026 | Sale to Issuer | 675,000 | โ | โ | 0 | Direct | โ | View Details | |
Chief Medical Officer | Restricted Stock Units | Derivative | Sep 11, 2026 | Sale to Issuer | 150,000 | โ | โ | 0 | Direct | โ | View Details |